Loading clinical trials...
Loading clinical trials...
The purpose of this study is to assess the long-term safety, tolerability and efficacy of LCZ696.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Novartis Pharmaceuticals
NCT06823947 · Healthy Volunteers Essential Hypertension
NCT07051811 · Essential Hypertension
NCT05845905 · Essential Hypertension
NCT06568640 · Essential Hypertension
NCT05638269 · Essential Hypertension, Liver Cancer, and more
Novartis Investigative Site
Chongqing, Chongqing Municipality
Novartis Investigative Site
Shijiazhuang, Hebei
Novartis Investigative Site
Hangzhou, Zhejiang
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions